(Q48863873)

16 February 2018

title

Gain of function of mutant TP53 in glioblastoma: prognosis and response to temozolomide. (English)

1 reference

16 February 2018

0 references

1 reference

Xiang Wang

1

1 reference

16 February 2018

Jin-Xiu Chen

2

1 reference

16 February 2018

Jin-Ping Liu

3

1 reference

16 February 2018

Chao You

4

1 reference

16 February 2018

Yan-Hui Liu

5

1 reference

16 February 2018

Qing Mao

6

1 reference

16 February 2018

publication date

19 November 2013

1 reference

16 February 2018

Annals of Surgical Oncology

published in

1 reference

16 February 2018

volume

21

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

1337-1344

1 reference

16 February 2018

https://scigraph.springernature.com/pub.10.1245/s10434-013-3380-0

exact match

0 references

cites work

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

O(6)-methylguanine-DNA methyltransferase gene (MGMT) expression in human glioblastomas in relation to patient characteristics and p53 accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

O6-methylguanine-DNA methyltransferase regulation by p53 in astrocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

p53-R175H mutant gains new function in regulation of doxorubicin-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

Reactivation of mutant p53: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

p53 protein accumulation and gene mutations in human glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

O6-methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

MGMT promoter hypermethylation is a frequent, early, and consistent event in astrocytoma progression, and not correlated with TP53 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3380-0

10.1245/S10434-013-3380-0

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

Dimensions Publication ID

0 references

1 reference

16 February 2018